PA2G4 and liver disorder: Indeed, our results showed that CHB patients with severe liver diseases had higher prevalence and serum levels of anti-EBP-1 autoantibody compared with those with mild diseases, suggesting that anti-EBP-1 autoantibody level is positively associated with liver damage in CHB.